Human and animal eosinophils contain a pow-
MATERIALS AND METHODS Patients. Patient 1 had eosinophilic gastroenteritis with peritonitis, and eosinophils were obtained from ascitic fluid as described (7) . Patients 2, 3 , and 4 were diagnosed as having the hypereosinophilic syndrome. Patient 3 presented with neurologic abnormalities including vertigo, weakness of arms and legs, and disorientation.
Purification of Eosinophils. Eosinophils from patient 1 were purified from ascitic fluid that contained a high proportion of eosinophils. Leukocytes from this ascitic fluid were partially purified by centrifugation after layering on Ficoll/Hypaque as described (7, 8) . After hypotonic lysis of erythrocytes, followed by three washes in normal saline, the leukocytes were resuspended in isotonic saline at a concentration of 3.5 x 107 cells per ml and stored at -75°C. This preparation contained 98% eosinophils, 0% neutrophils, and 2% mononuclear cells.
Eosinophils from patients 2, 3, and 4 were purified from eosinophil-rich leukocyte suspensions obtained by cytapheresis of patients on a Haemonetics semi-continuous-flow cell processor (Haemonetics, Natick, MA) (9) . The anti-coagulant used was 2% sodium citrate added to 6% hvdroxvethvl starch. After sedimentation of erythrocytes, cells in the supernatants were centrifuged at 200 x g for 5 min and washed once with Dulbecco's phosphate-buffered saline, pH 7.4 (PJNaCl). Residual erythrocytes were lysed by resuspending the pellets in 3 ml of Tris-buffered ammonium chloride, pH 7.2 (10), for every 1 ml of packed cells. After 2 min, the cells were centrifuged at 200 x g. Cells from patient 2, consisting of 100% eosinophils, were washed twice by centrifugation in PJ/NaCl and used directly to prepare eosinophil granules, major basic protein (MBP), and EDN. Cells from patient 3 were washed twice with PJNaCl and used to prepare Charcot-Leyden crystals (CLC) (11) and EDN.
A total of 1.75 x 1011 leukocytes was recovered from patient 3, of which 29% or 5.1 x 1010 cells were eosinophils, with 47% neutrophils and 25% mononuclear cells. Eosinophils were not purified further from this sample (see below). Cells from patient 4 were resuspended in 100 ml ofRPMI 1640 medium (GIBCO) containing 10% heat-inactivated fetal calf serum (RPMI/fetal calfserum), washed twice with centrifugation, and resuspended in the same medium. A modification of the method of Parillo and Fauci (12) was used to purify eosinophils from this suspension. A total of8.6 x 1010 cells, containing 47% eosinophils, was applied to 12 nylon wool columns, each containing 6 g of scrubbed nylon wool (Fenwal Laboratories, Deerfield, IL) in 60-ml syringes and equilibrated with RPMI/fetal calf serum at 37°C. Thirtv milliliters of the leukocyte suspension, containing 2.4 x 108 cells per ml, was applied to each column, followed Abbreviations: EDN, eosinophil-derived neurotoxin; P/NaCl, phosphate-buffered saline, pH 7.4; MBP, eosinophil granule major basic protein; CLC, Charcot-Leyden crystal. 5165
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by incubation at 370C for 15 min, and cells were eluted with 100 ml of RPMI/fetal calf serum at 370C. A total of 5.6 X 1010 cells was recovered for an overall eosinophil recovery of 97%. This preparation contained 70% eosinophils, 25% neutrophils, and 5% mononuclear cells.
Purification of Eosinophil Granules. Eosinophil granules were prepared from the eosinophil-rich leukocyte suspensions obtained from patients 2 and 4 as described in detail elsewhere (13) (14) (15) . Briefly, cells were gently washed once with ice-cold 0.25 M sucrose, resuspended in cold 0.25 M sucrose, disrupted by vigorous and repeated pipetting through a narrow-bore 10-ml calibrated pipette, and centrifuged to remove unbroken cells and large cell debris. The pellet was resuspended in 0.25 M sucrose and the extraction procedure was repeated four times. The supernatants from these extractions were centrifuged at 13,000 x g for 20 min to sediment the granules (Fig. 1) . EDN was purified from these eosinophil granules as described below.
Purification of Eosinophil MBP and CLC Proteins. The methods for purification of human MBP are described in detail elsewhere (13) (14) (15) Fig. 2a) , we suspected that EDN activity resided in the second protein peak (eluting between 27 and 33 ml in Fig. 2a) . Therefore, these fractions were concentrated and rechromatographed on a second Sephadex G-50 column at pH 7.4 as shown in Fig. 2b . Analysis of concentrated fractions from the major peak by NaDodSOJ polyacrylamide gel electrophoresis showed a band (Fig. 3b) with a molecular weight of approximately 18,000. Injection of this purified material produced a neurotoxic reaction in rabbits (Table 1 , EDN from patient 2).
We subsequently purified EDN from freeze-thaw extracts of human eosinophils (patients 1 and 3) and from acid extracts of purified eosinophil granules (patient 4) as described in Materials and Methods. These preparations retained the potent neurotoxic activity of the crude eosinophil and eosinophil granule extracts (Table 1) . NaDodSOJpolyacrylamide gel electrophoresis analysis of purified EDN from patient 1 (Fig. 3a) (Fig. 4) would eat and drink in a normal fashion if food and water were within reach. The latent period between injection of purified EDN and the onset of neurologic manifestations ranged between 3 and 11 days (Table 1) . Histopathologic Changes. On light microscopy, the histologic abnormalities found in rabbits injected with purified EDN were concentrated in cerebellum, pons, and spinal cord. The disappearance of Purkinje cells from the cerebellum that is a hallmark of the Gordon phenomenon was a constant pathologic (Fig. Sa) . The white matter of cerebellum, pons, and spinal cord showed gross spongiform changes (7 (25) , and eosinophilic meningoencephalitis associated with helminthic parasites (26, 27 
